Management of Endocrine Disease: Diagnosis and Management of Primary Aldosteronism: the Endocrine Society Guideline 2016 Revisited


The syndrome of primary aldosteronism (PA) is characterized by hypertension with excessive, autonomous aldosterone production and is usually caused by either a unilateral aldosterone-producing adenoma or bilateral adrenal hyperplasia. The diagnostic workup of PA is a sequence of three phases comprising screening tests, confirmatory tests and the differentiation of unilateral from bilateral forms. The latter step is necessary to determine the optimal treatment approach of unilateral laparoscopic adrenalectomy (for patients with unilateral PA) or medical treatment with a mineralocorticoid receptor antagonist (for patients with bilateral PA). Since the publication of the revised Endocrine Society guideline 2016, a number of key studies have been published. They challenge the recommendations of the guideline in some areas and confirm current practice in others. Herein, we present the recent developments and current approaches to the medical management of PA.

Authors: Tracy Ann Williams, Martin Reincke
Keywords: Endocrine Society guidelines, disease management
DOI Number: 10.1530/EJE-17-0990      Publication Year: 2017

To search for other research papers by topic, keyword, author, or year, please go to our Publications page.